Adamantane

Adamantane

SCHEMBL166190

C1C2CC3CC1CC(C2)C3.O=C(O)c1ccccc1.O=C(O)c1ccccc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Adamantane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.70
DAO P14920 1/20 0.70
NAPRT Q6XQN6 1/20 0.70
CES2 O00748 3/20 0.58
CES1 P23141 3/20 0.58
SRD5A2 P31213 2/20 0.58
TP53 P04637 1/20 0.52
FAAH O00519 1/20 0.50
CYP2C8 P10632 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.47
USP2 O75604 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA7 P36544 1/20 0.47
CHRNA4 P43681 1/20 0.47
TRPA1 O75762 1/20 0.46
P2RX7 Q99572 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adamantane SCHEMBL1653880 1.00 TSHR (0.70) TSHRDAONAPRTCES2CES1
Adamantane SCHEMBL163246 1.00 TSHR (0.70) TSHRDAONAPRTCES2CES1
Adamantane SCHEMBL11575814 1.00 TSHR (0.70) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL28043411 0.91 TSHR (0.64) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL2710114 0.86 TSHR (0.52) TSHRDAONAPRTCES2CES1
Benzophenone SCHEMBL29110866 0.85 ALDH1A1 (0.70) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL975929 0.84 TSHR (1.00) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL149318 0.84 TSHR (1.00) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL407365 0.84 TSHR (1.00) TSHRDAONAPRTCES2CES1
Benzoic Acid SCHEMBL137419 0.84 TSHR (1.00) TSHRDAONAPRTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2739169-B1 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS MASSACHUSETTS INST TECHNOLOGY (US) 2019-06-12 EP claimed
US-20140311507-A1 Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-10-23 US claimed
EP-2739169-A2 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS Massachusetts Institute Of Technology (US) 2014-06-11 EP claimed
WO-2013019865-A2 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-02-07 WO claimed
US-12630567-B2 High yield synthesis of metal-organic frameworks ExxonMobil Technology and Engineering Company (US) 2026-05-19 US disclosed
US-20250276300-A1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-09-04 US disclosed
EP-4291588-B1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-08-20 EP disclosed
CN-112352334-B Cathode for lithium-sulfur battery and cathode for sodium-sulfur battery 约翰霍普金斯大学 2025-03-25 CN disclosed
US-12227526-B2 Metal-organic framework materials comprising a diimine scaffold and methods for production thereof ExxonMobil Technology and Engineering Company (US) 2025-02-18 US disclosed
EP-3947396-B1 METAL-ORGANIC FRAMEWORK MATERIALS COMPRISING A DIIMINE SCAFFOLD AND METHODS FOR PRODUCTION THEREOF EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2024-12-11 EP disclosed
US-20240336636-A1 METAL-ORGANIC FRAMEWORK THE UNIVERSITY OF LIVERPOOL (GB) 2024-10-10 US disclosed
US-12107210-B2 Lithium-sulfur and sodium-sulfur battery cathodes THE JOHNS HOPKINS UNIVERSITY (US) 2024-10-01 US disclosed
US-20050004404-A1 Process for the alkoxylation of monools in the presence of metallo-organic framework materials BASF AKIENGESELLSCHAFT (DE) 2005-01-06 US disclosed
EP-1471997-A1 METHOD FOR STORING, ABSORBING AND EMITTING GASES USING NOVEL FRAMEWORK MATERIALS BASF AKTIENGESELLSCHAFT (DE) 2004-11-03 EP disclosed
WO-2004037895-A1 PROCESS FOR PRODUCING POLYALKYLENE CARBONATES BASF AKTIENGESELLSCHAFT (DE) 2004-05-06 WO disclosed
WO-2003102000-A1 SHAPED BODIES CONTAINING METAL-ORGANIC FRAMEWORKS BASF AKTIENGESELLSCHAFT (DE) 2003-12-11 WO disclosed
WO-2003101975-A1 EPOXIDATION PROCESS USING CATALYSTS CONTAINING METAL ORGANIC FRAMEWORK BASF AKTIENGESELLSCHAFT (DE) 2003-12-11 WO disclosed
US-6624318-B1 Process for the epoxidation of an organic compound with oxygen or an oxygen-delivering compounds using catalysts containing metal-organic frame-work materials BASF AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-6617467-B1 Polymerizing carbon dioxide with an alkylene oxide in the presence of a catalytic framework material comprising pores and a metal ion with a bidentate organic compound coordinated to the ion BASF AKTIENGESELLSCHAFT (DE) 2003-09-09 US disclosed
WO-2003064030-A1 METHOD FOR STORING, ABSORBING AND EMITTING GASES USING NOVEL FRAMEWORK MATERIALS BASF AKTIENGESELLSCHAFT (DE) 2003-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227526-B2 Metal-organic framework materials comprising a diimine scaffold and methods for production thereof PICALM, ILK, CAD TSHR 4193/4885DAO 1629/4885NAPRT 3343/4885
US-12630567-B2 High yield synthesis of metal-organic frameworks ODC1, POF1B, DDC TSHR 4032/4885DAO 525/4885NAPRT 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.